BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 31587946)

  • 1. Thickness-to-Height Ratio of Intravesical Prostatic Protrusion Predicts the Clinical Outcome and Morbidity of Prostatic Artery Embolization for Benign Prostatic Hyperplasia.
    Yu SCH; Cho CCM; Hung EHY; Zou J; Yuen BTY; Shi L; Chiu PKF; Yee SCH; Ng ACF
    J Vasc Interv Radiol; 2019 Nov; 30(11):1807-1816. PubMed ID: 31587946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized Clinical Trial of Balloon Occlusion versus Conventional Microcatheter Prostatic Artery Embolization for Benign Prostatic Hyperplasia.
    Bilhim T; Costa NV; Torres D; Pisco J; Carmo S; Oliveira AG
    J Vasc Interv Radiol; 2019 Nov; 30(11):1798-1806. PubMed ID: 31587950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical Prostatic Protrusion Does Not Influence the Efficacy of Prostatic Artery Embolization.
    Meira M; de Assis AM; Moreira AM; Antunes AA; Carnevale FC; Srougi M
    J Vasc Interv Radiol; 2021 Jan; 32(1):106-112. PubMed ID: 33127248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic Artery Embolization Using 100-300-μm Trisacryl Gelatin Microspheres to Treat Lower Urinary Tract Symptoms Attributable to Benign Prostatic Hyperplasia: A Single-Center Outcomes Analysis with Medium-Term Follow-up.
    Ayyagari R; Powell T; Staib L; Chapiro J; Raja A; Bhatia S; Chai T; Schoenberger S; Devito R
    J Vasc Interv Radiol; 2020 Jan; 31(1):99-107. PubMed ID: 31771896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-vesical Prostatic Protrusion (IPP) Can Be Reduced by Prostatic Artery Embolization.
    Lin YT; Amouyal G; Thiounn N; Pellerin O; Pereira H; Del Giudice C; Déan C; Sapoval M
    Cardiovasc Intervent Radiol; 2016 May; 39(5):690-695. PubMed ID: 26542027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic Artery Embolization for Benign Prostatic Hyperplasia: Prospective Randomized Trial of 100-300 μm versus 300-500 μm versus 100- to 300-μm + 300- to 500-μm Embospheres.
    Torres D; Costa NV; Pisco J; Pinheiro LC; Oliveira AG; Bilhim T
    J Vasc Interv Radiol; 2019 May; 30(5):638-644. PubMed ID: 31029381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Median Lobe Enlargement on Early Prostatic Artery Embolization Outcomes.
    Maron SZ; Sher A; Kim J; Lookstein RA; Rastinehad AR; Fischman A
    J Vasc Interv Radiol; 2020 Mar; 31(3):370-377. PubMed ID: 31956004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between intravesical prostatic protrusion and clinical outcomes in prostatic artery embolization.
    Boeken T; Di Gaeta A; Moussa N; Del Giudice C; Dean C; Pellerin O; Sapoval M
    Diagn Interv Imaging; 2021 Mar; 102(3):141-145. PubMed ID: 33423975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia.
    Carnevale FC; da Motta-Leal-Filho JM; Antunes AA; Baroni RH; Marcelino AS; Cerri LM; Yoshinaga EM; Cerri GG; Srougi M
    J Vasc Interv Radiol; 2013 Apr; 24(4):535-42. PubMed ID: 23434084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between intravesical prostatic protrusion and international prostate symptom score among Nigerian men with benign prostatic hyperplasia.
    Eze BU; Mbaeri TU; Oranusi KC; Abiahu JA; Nwofor AM; Orakwe JC; Mbonu OO
    Niger J Clin Pract; 2019 Apr; 22(4):454-459. PubMed ID: 30975947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results From a Prospective FDA-Approved Investigational Device Exemption Study.
    Salem R; Hairston J; Hohlastos E; Riaz A; Kallini J; Gabr A; Ali R; Jenkins K; Karp J; Desai K; Thornburg B; Casalino D; Miller F; Hofer M; Hamoui N; Mouli S
    Urology; 2018 Oct; 120():205-210. PubMed ID: 30036614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The First 48 Consecutive Patients with 3-Year Symptom Score Follow-Up Post-Prostate Artery Embolization (PAE) at a Single-Centre University Hospital.
    Maclean D; Harris M; Long J; Modi S; Bryant TJ; Hacking N
    Cardiovasc Intervent Radiol; 2020 Mar; 43(3):459-465. PubMed ID: 31797101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case-Control Comparison of Conventional End-Hole versus Balloon-Occlusion Microcatheter Prostatic Artery Embolization for Treatment of Symptomatic Benign Prostatic Hyperplasia.
    Ayyagari R; Powell T; Staib L; Chapiro J; Schoenberger S; Devito R; Pollak J
    J Vasc Interv Radiol; 2019 Sep; 30(9):1459-1470. PubMed ID: 31375451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostatic Artery Embolization in Nonindex Benign Prostatic Hyperplasia Patients: Single-center Outcomes for Urinary Retention and Gross Prostatic Hematuria.
    Ayyagari R; Powell T; Staib L; Chapiro J; Perez-Lozada JC; Bhatia S; Chai T; Schoenberger S; Devito R
    Urology; 2020 Feb; 136():212-217. PubMed ID: 31734349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, laboratorial, and urodynamic findings of prostatic artery embolization for the treatment of urinary retention related to benign prostatic hyperplasia. A prospective single-center pilot study.
    Antunes AA; Carnevale FC; da Motta Leal Filho JM; Yoshinaga EM; Cerri LM; Baroni RH; Marcelino AS; Cerri GG; Srougi M
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):978-86. PubMed ID: 23580116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Prostatic Artery Embolization on the Dynamic Component of Benign Prostate Hyperplasia as Assessed by Ultrasound Elastography: A Pilot Series.
    de Assis AM; Moreira AM; Carnevale FC; Marcelino ASZ; de Oliveira Cerri LM; Antunes AA; Srougi M; Cerri GG
    Cardiovasc Intervent Radiol; 2019 Jul; 42(7):1001-1007. PubMed ID: 30993369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medium- and Long-Term Outcome of Prostate Artery Embolization for Patients with Benign Prostatic Hyperplasia: Results in 630 Patients.
    Pisco JM; Bilhim T; Pinheiro LC; Fernandes L; Pereira J; Costa NV; Duarte M; Oliveira AG
    J Vasc Interv Radiol; 2016 Aug; 27(8):1115-22. PubMed ID: 27321890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of contrast-enhanced ultrasonography in detection of prostatic infarction after prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia.
    Moschouris H; Stamatiou K; Malagari K; Marmaridou K; Kladis-Kalentzis K; Kiltenis M; Papadogeorgopoulos N; Tsavari A; Manoloudaki K
    Diagn Interv Radiol; 2019 Mar; 25(2):134-143. PubMed ID: 30860077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenomatous-Dominant Benign Prostatic Hyperplasia (AdBPH) as a Predictor for Clinical Success Following Prostate Artery Embolization: An Age-Matched Case-Control Study.
    Little MW; Boardman P; Macdonald AC; Taylor N; Macpherson R; Crew J; Tapping CR
    Cardiovasc Intervent Radiol; 2017 May; 40(5):682-689. PubMed ID: 28194505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized Comparison of Prostatic Artery Embolization versus Transurethral Resection of the Prostate for Treatment of Benign Prostatic Hyperplasia.
    Insausti I; Sáez de Ocáriz A; Galbete A; Capdevila F; Solchaga S; Giral P; Bilhim T; Isaacson A; Urtasun F; Napal S
    J Vasc Interv Radiol; 2020 Jun; 31(6):882-890. PubMed ID: 32249193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.